McMaster Crest

Division of Neurology

Barbara Connolly

BSc, MD, FRCPC

Assistant Professor, Division of Neurology, Department of Medicine

 

 

 

 

 

Education and Professional Standing

Clinical Fellowship, Movement Disorders, University of Toronto, 2013
FRCPC, Neurology, McMaster University, 2011
MD, University of Western Ontario, 2006
BSc (Honours Life Sciences), Queen’s University, 2002

Clinical and Academic Interests

Clinical interests include evaluation and management of movement disorders including Parkinson’s disease and other parkinsonian disorders, Huntington’s disease and other choreiform disorders, tremor, ataxia, dystonia, and myoclonus, and teaching medical learners in this area of specialty. Dr. Connolly also performs botulinum toxin injections for facial, cervical, and limb dystonia.

Research interests in the area of movement disorders involve clinical trial participation and this is currently in development.

Selected Publications

  1. Mestre T, Shah BB, Connolly BS, Aquino C, Dhakeel A, Walsh R, Ghate T, Lui J, Fox SH. Famotidine, a histamine H2 receptor antagonist, does not reduce levodopa-induced dyskinesia in Parkinson’s disease: a proof of concept study. Mov Disord Clin Practice. In Press.
  2. Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670-83.
    Connolly BS, Hazrati LN, Lang AE. Neuropathological findings in chorea-acanthocytosis: new insights into mechanisms underlying parkinsonism and seizures. Acta Neuropathol. 2014;127(4):613-5.
  3. Connolly B, Fox SH. Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson’s disease. Neurotherapeutics. 2014;119(1):78-91.
  4. Connolly BS, Marras C. Management of non-motor symptoms of Parkinson’s disease. In JS Hawley, MJ Armstrong, & WJ Weiner (Eds.). Parkinson’s disease: improving patient care. Eds. Oxford American Neurology Library, 2014.
  5. Salmon A, Hayman-Abello B, Connolly B, McLachlan RS. Temporal lobectomy with delayed amnesia following a new lesion on the other side. Can J Neurol Sci. 2014;41(2):220-5.
  6. Lach B, Connolly B, Wuthrich C, Koralnik IJ. Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis. Neuropathology. 2014;34(1)39-44.
  7. Connolly BS, Fox SH. Drug treatments for the neuropsychiatric complications of Parkinson’s disease. Expert Rev Neurother. 2012:12(12):1439-49.